GFCR Integrative Program (cancer therapy)
The Integrative Program from the Gateway for Cancer Research funds integrative oncology research that pairs conventional therapies with evidence-based integrative therapies to manage symptoms and side effects from treatment. Grants are typically 2-5 years in duration with award amounts from 200,000 to 1.5 million USD. Applicants are required to first submit a letter of intent (LOI). Eligible applicants will be given 4-5 weeks to complete their full application. The next LOI closing date is July 25, 2022.
Create or sign in to your free account for more functionalities, including a full display of the eligibility criteria such as location and citizenship requirements.